All of the following are AIDS defining illnesses except:

Explanation

## Correct Answer: C. Oral candidiasis Oral candidiasis is NOT an AIDS-defining illness in the current CDC/WHO classification. While oral candidiasis is a common opportunistic infection in HIV-positive patients and indicates immunosuppression (typically CD4 <200 cells/μL), it does not meet the threshold for AIDS diagnosis. The CDC 1993 revised classification reserves the AIDS-defining diagnosis for **esophageal candidiasis** (not oral), which represents more severe immunosuppression and disseminated disease. Oral candidiasis is considered an early marker of immune decline and warrants antiretroviral therapy initiation in India (per NACO guidelines), but it is classified as a non-AIDS-defining OI. In contrast, invasive cervical cancer, HIV encephalopathy, and TB of any site are all explicitly listed as AIDS-defining illnesses. This distinction is critical for Indian clinicians: while oral thrush is managed aggressively (fluconazole 100–200 mg daily), it does not trigger the formal AIDS diagnosis that carries epidemiological and prognostic weight in India's TB-HIV co-infection surveillance. ## Why the other options are wrong **A. Invasive cervical cancer** — This IS an AIDS-defining illness. Invasive cervical cancer (not CIN) is explicitly listed in CDC 1993 criteria and occurs at CD4 <50 cells/μL due to loss of HPV immune control. In India, cervical cancer screening is recommended for all HIV-positive women; its presence confirms AIDS diagnosis regardless of CD4 count. **B. Encephalopathy attributed to HIV** — This IS an AIDS-defining illness. HIV encephalopathy (also called HIV dementia or HAND) is a direct CNS manifestation of advanced HIV and is listed in CDC criteria. It indicates severe immunosuppression and is a formal AIDS diagnosis trigger in Indian HIV management protocols. **D. Mycobacterium tuberculosis of any site** — This IS an AIDS-defining illness. TB of ANY site (pulmonary or extrapulmonary) is an AIDS-defining condition in HIV-positive patients, reflecting the high TB-HIV co-infection burden in India. This is a cornerstone of RNTCP-NACO integrated guidelines and triggers immediate ART initiation. ## High-Yield Facts - **Esophageal candidiasis** (not oral) is the AIDS-defining candida infection; oral thrush is a non-AIDS-defining OI. - **CD4 <50 cells/μL** is the threshold for invasive cervical cancer as an AIDS-defining illness in HIV-positive women. - **TB of any site** (pulmonary, lymph node, meningitis, disseminated) is AIDS-defining in HIV patients per CDC 1993 and RNTCP-NACO guidelines. - **HIV encephalopathy** requires cognitive decline, motor dysfunction, or behavioral change; it is a direct CNS effect, not a secondary OI. - Oral candidiasis typically appears at **CD4 <200 cells/μL** and is managed with fluconazole; it warrants ART but does not define AIDS. ## Mnemonics **AIDS-Defining OIs (Remember: Esophageal, not Oral)** **E**sophageal candidiasis, **C**ryptococcal meningitis, **C**ytomegalovirus, **M**ycobacterium avium complex, **P**neumocystis pneumonia, **T**oxoplasmosis. Oral candidiasis is the trap—it's common but NOT AIDS-defining. **TB-HIV Rule in India** **Any TB + HIV = AIDS diagnosis** (per RNTCP-NACO). Pulmonary, extrapulmonary, disseminated—all are AIDS-defining. This is unique to TB and reflects India's epidemic. ## NBE Trap NBE exploits the high prevalence of oral candidiasis in Indian HIV clinics: students see thrush frequently and assume it must be AIDS-defining, conflating "common OI" with "AIDS-defining OI." The trap is forgetting that esophageal (not oral) candidiasis is the threshold condition. ## Clinical Pearl In Indian HIV clinics, oral candidiasis is often the first sign prompting CD4 testing and ART initiation—but it does NOT change the patient's epidemiological classification to AIDS until esophageal involvement or another AIDS-defining illness appears. This distinction matters for TB-HIV surveillance and prognostic counseling. _Reference: CDC 1993 Revised Classification of HIV Infection; Harrison Ch. 197 (HIV/AIDS); NACO Guidelines on ART and OI Management (India)_